Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy.
about
An integrative view on sex differences in brain tumorsImmunological aspects of gliomasComparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.History and current state of immunotherapy in glioma and brain metastasis.Progress in active-specific immunotherapy of brain malignancies.Cell-mediated immunotherapy: a new approach to the treatment of malignant glioma.Unarmed, tumor-specific monoclonal antibody effectively treats brain tumorsImmunobiologic aspects of the brain and human gliomas. A reviewA preliminary study utilizing viable HLA mismatched cultured glioma cells as adjuvant therapy for patients with malignant gliomas.Immunotherapy for acute myelogenous leukaemiaActive immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study.Effects of C. parvum on growth and induction of intracerebral tumours in miceImmunotherapy for human glioma: innovative approaches and recent results.Combined modality therapy for intracranial tumors.Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patientsHeat shock protein-peptide complex in the treatment of glioblastoma.Levamisole in the treatment of glioblastoma multiforme.Adjuvant therapy for adenocarcinoma of the kidney: present position and prospects.Recent concepts in the conservative treatment of intracranial tumours in children.Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms.Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.Hypofractionated radiation therapy and concurrent cisplatin in malignant cerebral gliomas. Rapid palliation in low performance status patients.Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy.Radiation therapy for brain tumors.Dendritic cells are essential for priming but inefficient for boosting antitumour immune response in an orthotopic murine glioma model.Surface antigen(s) common to human astrocytoma cells.Immunotherapy of prolactinoma with a T helper 1 activator adjuvant and autoantigens: a case report.Tumoural antigens on experimental and human glioblastoma.
P2860
Q26829861-EBA29DA1-91F8-4259-8916-55894856BCF6Q30499088-5EC75C2B-C396-412B-A001-BBE21B69CCDCQ33477348-65CF90D1-6169-4B9F-A917-4E80644E40D9Q33656811-788033AF-FFDD-44F1-BDE7-B9D89C7332A4Q34075068-1A4C882A-CD9C-474C-9A57-FCF762C1D645Q35113661-B8EBCE16-26EC-4CB6-86EA-CCBF30FF8CF1Q35162055-D943FB51-340A-4358-9DAA-252599CE4333Q35862927-9B55AB79-3103-4969-BFBD-635B834C0A77Q35992089-B9051476-1ADE-42D5-8B1C-E1FF315F6280Q36040337-911996EB-5785-4105-AB77-64CC8C73C912Q36041590-89181D8C-4A7D-4C36-BCB9-E1969EF8D6DDQ36069052-B3EDB437-051D-4266-82F1-33514AF42837Q36284489-FC17F5DC-3083-4339-B19B-E529CECF5CD6Q36311944-7BE3F1F3-AA95-443F-BC3B-5DAD6F7DB1E5Q37186248-6BD677E7-B2D3-4EFE-BADC-49591A8DA9A8Q37475929-9A7F7339-47BE-445F-8B75-51D1A5505857Q37892575-040FE9E9-BC0A-4674-8477-47E396761D10Q38479049-EF5A12E7-2C27-41DE-A88F-FCE2DB7ACD9FQ39927767-32E09A81-86F3-41F6-9212-C1104E4D9104Q40278341-D519C6E1-DA2C-4A5A-A22A-61CB0FD83840Q41005830-D6523CA0-BF40-4586-9779-C87B2AB687B8Q41435191-0013D7B2-AB84-4AD6-93A3-02EF2DFFF951Q44195619-81B818ED-7A26-4DA2-B3C5-51503265D080Q44856072-5CD89136-2902-4C9A-B5D8-D9B5FBD49A3CQ46096525-7A13BBFB-6114-4B8B-87CD-221294D255E5Q46678987-DF54327D-8999-4B4D-8EA1-428493287A0EQ47823022-C603F5EF-D358-4089-BEED-F44A62CBA0E6Q48252982-88B823B5-0606-4280-B052-542847534BDDQ55491177-814209B5-5BBA-4DB9-9ED3-FCB1E980C50F
P2860
Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
Glioblastoma multiforme: a con ...... ical surgery and radiotherapy.
@ast
Glioblastoma multiforme: a con ...... ical surgery and radiotherapy.
@en
type
label
Glioblastoma multiforme: a con ...... ical surgery and radiotherapy.
@ast
Glioblastoma multiforme: a con ...... ical surgery and radiotherapy.
@en
prefLabel
Glioblastoma multiforme: a con ...... ical surgery and radiotherapy.
@ast
Glioblastoma multiforme: a con ...... ical surgery and radiotherapy.
@en
P2093
P2860
P356
P1476
Glioblastoma multiforme: a con ...... ical surgery and radiotherapy.
@en
P2093
Alexander PA
Peckham MJ
Richardson AE
P2860
P2888
P304
P356
10.1038/BJC.1973.30
P407
P577
1973-03-01T00:00:00Z